<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">problendo</journal-id><journal-title-group><journal-title xml:lang="en">Problems of Endocrinology</journal-title><trans-title-group xml:lang="ru"><trans-title>Проблемы Эндокринологии</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0375-9660</issn><issn pub-type="epub">2308-1430</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/probl13459</article-id><article-id custom-type="elpub" pub-id-type="custom">problendo-13459</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Carbohidrates metabolism disturbancies</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Нарушения углеводного обмена</subject></subj-group></article-categories><title-group><article-title>Predicting Anxiety in Individuals with Diabetes: A Comparative Analysis of Machine Learning Algorithms</article-title><trans-title-group xml:lang="ru"><trans-title>Predicting Anxiety in Individuals with Diabetes: A Comparative Analysis of Machine Learning Algorithms</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5772-5534</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Bourkhime</surname><given-names>H.</given-names></name><name name-style="western" xml:lang="en"><surname>Bourkhime</surname><given-names>H.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Hind Bourkhime, Medical Informatics Specialist, Medical Informatics and Data science Unit, Laboratory of Epidemiology, Clinical Research and Community Health, Faculty of Medicine and Pharmacy of Fez;  Diagnostic center; Medical and Pharmaceutical Sciences and Translational Research, Laboratory of Epidemiology and Health Sciences Research, Faculty of Medicine and Pharmacy of Fez</p><p>B.P. 1893, Km 2.200 Route de Sidi Harazem, Fès 30070,</p></bio><bio xml:lang="en"><p>Hind Bourkhime, Medical Informatics Specialist</p><p>B.P. 1893, Km 2.200 Route de Sidi Harazem, Fès 30070</p></bio><email xlink:type="simple">hbourkhime@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1786-5049</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Qarmiche</surname><given-names>N.</given-names></name><name name-style="western" xml:lang="en"><surname>Qarmiche</surname><given-names>N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Noura Qarmiche, Associate Professor in Bioinformatics, Laboratory of Artificial Intelligence, Data Science and Emerging Systems, National School of Applied Sciences Fez; Department of Epidemiology, Clinical Research and Community Health, Faculty of Medicine and Pharmacy of Fez</p><p>Fez</p></bio><bio xml:lang="en"><p>Noura Qarmiche, Associate Professor in Bioinformatics</p><p>Fez</p></bio><email xlink:type="simple">noura.qarmiche@usmba.ac.ma</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1011-504X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Benmaama</surname><given-names>S.</given-names></name><name name-style="western" xml:lang="en"><surname>Benmaamar</surname><given-names>S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Soumaya Benmaamar, Associate Professor in Epidemiology, Diagnostic center; Department of Epidemiology, Clinical Research and Community Health, Faculty of Medicine and Pharmacy of Fez</p><p>Fez</p></bio><bio xml:lang="en"><p>Soumaya Benmaamar, Associate Professor in Epidemiology</p><p>Fez</p></bio><email xlink:type="simple">soumaya.benmaamar@usmba.ac.ma</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Lazar</surname><given-names>N.</given-names></name><name name-style="western" xml:lang="en"><surname>Lazar</surname><given-names>N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Nada Lazar, Endocrinology Specialist, Diagnostic center; Department of Endocrinology, Diabetology, Metabolic Diseases and Nutrition</p><p>Fez</p></bio><bio xml:lang="en"><p>Nada Lazar, Endocrinology Specialist</p><p>Fez</p></bio><email xlink:type="simple">nada.lazar@usmba.ac.ma</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Omari</surname><given-names>M.</given-names></name><name name-style="western" xml:lang="en"><surname>Omari</surname><given-names>M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Mohammed Omari, Medical Informatics Specialist, Medical Informatics and Data science Unit, Laboratory of Epidemiology, Clinical Research and Community Health, Faculty of Medicine and Pharmacy of Fez; Diagnostic center</p><p>Fez</p></bio><bio xml:lang="en"><p>Mohammed Omari, Medical Informatics Specialist</p><p>Fez</p></bio><email xlink:type="simple">mohammed.omari@usmba.ac.ma</email><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Berraho</surname><given-names>M.</given-names></name><name name-style="western" xml:lang="en"><surname>Berraho</surname><given-names>M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Mohamed Berraho, Full Professor of Epidemiology, Diagnostic center; Medical and Pharmaceutical Sciences and Translational Research, Laboratory of Epidemiology and Health Sciences Research, Faculty of Medicine and Pharmacy of Fez; Department of Epidemiology, Clinical Research and Community Health, Faculty of Medicine and Pharmacy of Fez</p><p>Fez</p></bio><bio xml:lang="en"><p>Mohamed Berraho, Full Professor of Epidemiology</p><p>Fez</p></bio><email xlink:type="simple">maberraho@gmail.com</email><xref ref-type="aff" rid="aff-6"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Tachfouti</surname><given-names>N.</given-names></name><name name-style="western" xml:lang="en"><surname>Tachfouti</surname><given-names>N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Mohamed Berraho, Full Professor of Epidemiology, Diagnostic center; Department of Epidemiology, Clinical Research and Community Health, Faculty of Medicine and Pharmacy of Fez</p><p>Fez</p></bio><bio xml:lang="en"><p>Nabil Tachfouti, Full Professor of Epidemiology</p><p>Fez</p></bio><email xlink:type="simple">nabil.tachfouti@usmba.ac.ma</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>EL Fakir</surname><given-names>S</given-names></name><name name-style="western" xml:lang="en"><surname>EL Fakir</surname><given-names>S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Samira EL Fakir, Full Professor of Epidemiology, Diagnostic center; Department of Epidemiology, Clinical Research and Community Health, Faculty of Medicine and Pharmacy of Fez</p><p>Fez</p></bio><bio xml:lang="en"><p>Samira EL Fakir, Full Professor of Epidemiology</p><p>Fez</p></bio><email xlink:type="simple">samira.elfakir@usmba.ac.ma</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>El Ouahabi</surname><given-names>H.</given-names></name><name name-style="western" xml:lang="en"><surname>El Ouahabi</surname><given-names>H.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Samira EL Fakir, Full Professor of Epidemiology, Diagnostic center; Department of Endocrinology, Diabetology, Metabolic Diseases and Nutrition</p><p>Fez</p></bio><bio xml:lang="en"><p>Hanan El Ouahabi, Full Professor of Endocrinology</p><p>Fez</p></bio><email xlink:type="simple">hanan.elouahabi@usmba.ac.ma</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Otmani</surname><given-names>N.</given-names></name><name name-style="western" xml:lang="en"><surname>Otmani</surname><given-names>N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Nada Otmani, Full Professor of Medical Informatics, Medical Informatics and Data science Unit, Laboratory of Epidemiology, Clinical Research and Community Health, Faculty of Medicine and Pharmacy of Fez; Diagnostic center</p><p>Fez</p></bio><bio xml:lang="en"><p>Nada Otmani, Full Professor of Medical Informatics</p><p>Fez</p></bio><email xlink:type="simple">nada.otmani@usmba.ac.ma</email><xref ref-type="aff" rid="aff-7"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Sidi Mohamed Ben Abdellah University; Hassan II University Hospital; Sidi Mohamed Ben Abdellah University</institution><country>Марокко</country></aff><aff xml:lang="en"><institution>Medical Informatics and Data science Unit, Laboratory of Epidemiology, Clinical Research and Community Health, Faculty of Medicine and Pharmacy of Fez, Sidi Mohamed Ben Abdellah University; Diagnostic center, Hassan II University Hospital; Medical and Pharmaceutical Sciences and Translational Research, Laboratory of Epidemiology and Health Sciences&#13;
Research, Faculty of Medicine and Pharmacy of Fez, Sidi Mohamed Ben Abdellah University</institution><country>Morocco</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Sidi Mohamed Ben Abdellah University;  Sidi Mohamed Ben Abdellah University</institution><country>Марокко</country></aff><aff xml:lang="en"><institution>Laboratory of Artificial Intelligence, Data Science and Emerging Systems, National School of Applied Sciences Fez, Sidi Mohamed Ben Abdellah University; Department of Epidemiology, Clinical Research and Community Health, Faculty of Medicine and Pharmacy of Fez, Sidi Mohamed Ben Abdellah University</institution><country>Morocco</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Hassan II University Hospital; Sidi Mohamed Ben Abdellah University</institution><country>Марокко</country></aff><aff xml:lang="en"><institution>Diagnostic center, Hassan II University Hospital; Department of Epidemiology, Clinical Research and Community Health, Faculty of Medicine and Pharmacy of Fez, Sidi Mohamed Ben Abdellah University</institution><country>Morocco</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>Hassan II University Hospital</institution><country>Марокко</country></aff><aff xml:lang="en"><institution>Diagnostic center, Hassan II University Hospital; Department of Endocrinology, Diabetology, Metabolic Diseases and Nutrition, Hassan II University Hospital</institution><country>Morocco</country></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru"><institution>Sidi Mohamed Ben Abdellah University; Hassan II University Hospital</institution><country>Марокко</country></aff><aff xml:lang="en"><institution>Medical Informatics and Data science Unit, Laboratory of Epidemiology, Clinical Research and Community Health, Faculty of Medicine and Pharmacy of Fez, Sidi Mohamed Ben Abdellah University; Diagnostic center, Hassan II University HospitalDiagnostic center, Hassan II University Hospital</institution><country>Morocco</country></aff></aff-alternatives><aff-alternatives id="aff-6"><aff xml:lang="ru"><institution>Hassan II University Hospital; Sidi Mohamed Ben Abdellah University</institution><country>Марокко</country></aff><aff xml:lang="en"><institution>Diagnostic center, Hassan II University Hospital; Medical and Pharmaceutical Sciences and Translational Research, Laboratory of Epidemiology and Health Sciences Research, Faculty of Medicine and Pharmacy of Fez, Sidi Mohamed Ben Abdellah University; Department of Epidemiology, Clinical Research and Community Health, Faculty of Medicine and Pharmacy of Fez, Sidi Mohamed Ben Abdellah University</institution><country>Morocco</country></aff></aff-alternatives><aff-alternatives id="aff-7"><aff xml:lang="ru"><institution>Sidi Mohamed Ben Abdellah University; Hassan II University Hospital</institution><country>Марокко</country></aff><aff xml:lang="en"><institution>Medical Informatics and Data science Unit, Laboratory of Epidemiology, Clinical Research and Community Health, Faculty of Medicine and Pharmacy of Fez, Sidi Mohamed Ben Abdellah University;  Diagnostic center, Hassan II University Hospital</institution><country>Morocco</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>20</day><month>05</month><year>2026</year></pub-date><volume>72</volume><issue>2</issue><fpage>54</fpage><lpage>60</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Bourkhime H., Qarmiche N., Benmaamar S., Lazar N., Omari M., Berraho M., Tachfouti N., EL Fakir S., El Ouahabi H., Otmani N., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Bourkhime H., Qarmiche N., Benmaama S., Lazar N., Omari M., Berraho M., Tachfouti N., EL Fakir S., El Ouahabi H., Otmani N.</copyright-holder><copyright-holder xml:lang="en">Bourkhime H., Qarmiche N., Benmaamar S., Lazar N., Omari M., Berraho M., Tachfouti N., EL Fakir S., El Ouahabi H., Otmani N.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.probl-endojournals.ru/jour/article/view/13459">https://www.probl-endojournals.ru/jour/article/view/13459</self-uri><abstract><p>Diabetes is a long-term costly burden that increases the vulnerability of individuals to develop anxiety disorders. Consequently, effective management of diabetes anxiety in diabetics can significantly improve overall patient care. This paper presents a comparative analysis of three machine learning algorithms, namely Logistic Regression (LR), Support Vector Machine (SVM), and Decision Tree (DT), in predicting anxiety among diabetics. A Moroccan dataset was utilized, and a grid search approach was employed for hyperparameters tuning.</p><p>The findings demonstrate promising results in terms of the algorithms’ performance. The Decision Tree algorithm exhibited the highest accuracy, achieving an impressive 96% in predicting anxiety among diabetics. SVM followed with an accuracy rate of 69%, while LR achieved 61%. These outcomes provide valuable insights for further research endeavors aimed at refining the prediction models.</p><p>In conclusion, the study highlights the potential of machine learning algorithms in predicting anxiety disorders among individuals with diabetes. The high accuracy demonstrated by the Decision Tree model suggests its potential as a reliable tool in clinical settings. Further investigations are warranted to validate these results and explore the applicability of these models in real-world scenarios, ultimately enhancing the management and well-being of individuals with diabetes and comorbid anxiety disorders.</p></abstract><trans-abstract xml:lang="ru"><p>Diabetes is a long-term costly burden that increases the vulnerability of individuals to develop anxiety disorders. Consequently, effective management of diabetes anxiety in diabetics can significantly improve overall patient care.</p><p>This paper presents a comparative analysis of three machine learning algorithms, namely Logistic Regression (LR), Support Vector Machine (SVM), and Decision Tree (DT), in predicting anxiety among diabetics. A Moroccan dataset was utilized, and a grid search approach was employed for hyperparameters tuning.</p><p>The findings demonstrate promising results in terms of the algorithms’ performance. The Decision Tree algorithm exhibited the highest accuracy, achieving an impressive 96% in predicting anxiety among diabetics. SVM followed with an accuracy rate of 69%, while LR achieved 61%. These outcomes provide valuable insights for further research endeavors aimed at refining the prediction models.</p><p>In conclusion, the study highlights the potential of machine learning algorithms in predicting anxiety disorders among individuals with diabetes. The high accuracy demonstrated by the Decision Tree model suggests its potential as a reliable tool in clinical settings. Further investigations are warranted to validate these results and explore the applicability of these models in real-world scenarios, ultimately enhancing the management and well-being of individuals with diabetes and comorbid anxiety disorders.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>Diabetes</kwd><kwd>Anxiety</kwd><kwd>Machine Learning</kwd><kwd>prediction</kwd><kwd>risk</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Diabetes</kwd><kwd>Anxiety</kwd><kwd>Machine Learning</kwd><kwd>prediction</kwd><kwd>risk</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">No funding.</funding-statement><funding-statement xml:lang="en">No funding.</funding-statement></funding-group></article-meta></front><body><sec><title>INTRODUCTION</title><p>Diabetes mellitus is a prevalent chronic disease that ranks among the top 10 causes of death in adults worldwide [<xref ref-type="bibr" rid="cit1">1</xref>]. The International Diabetes Federation reports that the global prevalence of diabetes in 2019 was estimated to be 9.3%, affecting 463 million individuals, and it is projected to rise to 10.9%, impacting 700 million people by 2045 [<xref ref-type="bibr" rid="cit1">1</xref>]. Disturbingly, diabetes claimed the lives of 4 million individuals in 2017 [<xref ref-type="bibr" rid="cit1">1</xref>]. In the context of Morocco, approximately 2.5 million adults have diabetes, with nearly 50% of them being unaware of their condition [<xref ref-type="bibr" rid="cit2">2</xref>].</p><p>Recent studies have highlighted the intricate relationship between diabetes and anxiety. A study conducted in a Moroccan region in 2021 found that the prevalence of anxiety among individuals with diabetes was 29.6% [<xref ref-type="bibr" rid="cit3">3</xref>]. Recognizing the significance of addressing the psychological aspect of diabetes management is essential, as anxiety can exacerbate diabetes-related complications, hinder effective disease management, and adversely affect overall patient well-being [4–6].</p><p>Machine learning (ML) models have emerged as efficient tools for tackling healthcare challenges, enabling disease prediction and facilitating informed decision-making regarding patient management, thus improving healthcare services [7-8]. In this context, developing an accurate ML model for predicting anxiety in individuals with diabetes is crucial for several reasons.</p><p>Integrating anxiety prediction into routine care will enable healthcare providers to identify at-risk patients earlier, allowing for timely psychological interventions that prevent anxiety symptoms from escalating. This approach will also improve personalized treatment plans by addressing both the physical and mental health needs of diabetic patients [7–8].</p><p>By leveraging the power of ML, this study aims to develop a model for predicting anxiety in individuals with diabetes. To identify the algorithm that exhibits optimal performance, a comparative analysis of three ML algorithms was conducted, paving the way for future investigations in this domain. This approach not only supports the holistic care of diabetic patients but also underscores the potential of advanced technologies in revolutionizing endocrinological practice.</p></sec><sec><title>RELATED WORKS</title><p>Generally, in the field of mental health research, the prediction of anxiety disorders has garnered significant attention. Previous studies have employed various machine learning algorithms, including Artificial Neural Networks (ANNs) [<xref ref-type="bibr" rid="cit9">9</xref>], Naïve Bayes (NB)[<xref ref-type="bibr" rid="cit10">10</xref>], Bayes Network (BN)[<xref ref-type="bibr" rid="cit10">10</xref>], Support Vector Machine (SVM) [<xref ref-type="bibr" rid="cit9">9</xref>], Decision trees (DTs) [<xref ref-type="bibr" rid="cit9">9</xref>], Local Nearest Neighbor (LNN) [<xref ref-type="bibr" rid="cit10">10</xref>], Multilayer Perceptron (MLP) [<xref ref-type="bibr" rid="cit10">10</xref>], Radial Basis Function Network (RBFN) [<xref ref-type="bibr" rid="cit10">10</xref>], Linear Regression (LR) [<xref ref-type="bibr" rid="cit9">9</xref>], Random Forest (RF) [<xref ref-type="bibr" rid="cit10">10</xref>], and J48 [<xref ref-type="bibr" rid="cit10">10</xref>]. These algorithms have been applied to diverse datasets, encompassing the online DASS42 scale [<xref ref-type="bibr" rid="cit10">10</xref>], electronic health records [<xref ref-type="bibr" rid="cit11">11</xref>], and other relevant tools [<xref ref-type="bibr" rid="cit9">9</xref>].</p><p>Nonetheless, despite the advancements in predicting anxiety disorders, there remains a dearth of research specifically focusing on the application of machine learning for anxiety prediction among individuals with diabetes [<xref ref-type="bibr" rid="cit12">12</xref>]. Notably, a recent study has emerged with the objective of developing a machine learning model that predicts mental health risk in diabetic patients [<xref ref-type="bibr" rid="cit13">13</xref>]. This model incorporates crucial data such as demographics, glucometer data, and coaching information [<xref ref-type="bibr" rid="cit13">13</xref>]. The emerging interest in exploring the intersection of machine learning and anxiety prediction in the context of diabetes underscores the growing importance of further investigations in this field.</p></sec><sec><title>METHOD AND MATERIALS</title><p>The proposed methodology in this study can be summarized in 3 steps: Data preparation, machine learning training and machine learning testing. Figure 1 demonstrates the data analysis framework for the predictability steps. Below, we provide further details about various components of the methodological framework.</p><fig id="fig-1"><caption><p>Figure 1: The methodological framework used in this study.</p><p>HT: Hyperparameters Tuning; LR: Logistic Regression; SVM: Support Vector MachineDT: Decision Tree.</p></caption><graphic xlink:href="problendo-72-2-g001.jpeg"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/problendo/2026/2/bNMcx6XyTjAdE8R1aVFLNyWcYbGVA8qrMV876V4R.jpeg</uri></graphic></fig></sec><sec><title>1) Data Source</title><p>The dataset used was extracted from a previous cross-sectional study conducted at Hassan II University-Hospital of Fez, Morroco, between 2019 and 2020 [<xref ref-type="bibr" rid="cit3">3</xref>]. This study estimated the prevalence of anxiety and depression in a total of 243 patients with diabetes mellitus and identified their determinants in this region [<xref ref-type="bibr" rid="cit3">3</xref>].There were 72 cases of anxiety.</p></sec><sec><title>2) Attributes Description</title><p>Predictive models can offer the most value when they are able to support real-time clinical decision making. To maintain the feasibility of applying the algorithms during admission to an acute healthcare setting, we included patient data readily available to clinicians (eg, age, sex, marital status, social insurance, diabetes types, duration of progression, treatment protocol, number of comorbidities, and glycated hemoglobin (HBA1C)) to highlight the sustainability of screening and to aid in real-time proactive decision making.</p><p>For the assessment of anxiety status (Anxiety), the Hospital Anxiety and Depression Scale (HADS) [<xref ref-type="bibr" rid="cit14">14</xref>], validated in Moroccan context [<xref ref-type="bibr" rid="cit15">15</xref>], was used. It is a self-report scale that identifies anxiety and depressive disorders. It has 14 items. For each item, the response is scored from 0 to 3 on a scale according to the intensity of the symptom during the past week. For the anxiety subscale, threshold values were determined: 0–7: normal; &gt;7 anxiety symptoms [14–15]. This anxiety variable was used as a qualitative variable where patients without anxiety took 0 as the score and anxious patients took 1.</p><p>Table I shows the description of these attributes and their values.</p><table-wrap id="table-1"><caption><p>Table I. Description of selected attributes and their values</p></caption><table><tbody><tr><td>Attributes</td><td>Description</td><td>N (%)</td></tr><tr><td>Age in Years (Mean±Standard Error)</td><td> </td><td>48.07±14.25</td></tr><tr><td>Gender</td><td>Male</td><td>102 (42%)</td></tr><tr><td>Female</td><td>141 (58%)</td></tr><tr><td>Marital Status</td><td>Single</td><td>56 (24.5%)</td></tr><tr><td>Married</td><td>146 (63.8%)</td></tr><tr><td>Divorced or Widowed</td><td>27 (11.8%)</td></tr><tr><td>Social Insurance</td><td>Without</td><td>88 (37.4%)</td></tr><tr><td>With</td><td>147 (62.6%)</td></tr><tr><td>Diabetes Types</td><td>Type1</td><td>67 (27.6%)</td></tr><tr><td>Type2</td><td>176 (72.4%)</td></tr><tr><td>Duration of evolution in Years (Median (Range))</td><td> </td><td>3 (30)</td></tr><tr><td>Therapeutic Protocol</td><td>Oral Antidiabetics</td><td>124 (51%)</td></tr><tr><td>Insulin</td><td>36 (14.8%)</td></tr><tr><td>Both</td><td>83 (34.2%)</td></tr><tr><td>Number of comorbidities (Median (Range))</td><td> </td><td>0 (3)</td></tr><tr><td>Glycated hemoglobin hba1c in numbers (HBA1C) (Mean±Standard Error)</td><td> </td><td>10.05±2.80</td></tr></tbody></table></table-wrap></sec><sec><title>3) Data Preprocessing</title><p>3-1- Replacing missing data.</p><p>In this study the Data sets contained some attributes with missing values. Features with more than a 50% missing values threshold will be removed [<xref ref-type="bibr" rid="cit16">16</xref>].</p><p>In view to deal with these missing values, we used an imputation technique as for quantitative variable, especially “HBA1C”, missing values were replaced by the mean of the non-missing values in this column.</p><p>For the qualitative variables, we replaced them by the most frequent value.</p><p>3-2- Normalizing numeric features.</p><p>The MinMaxScaler from sklearn preprocessing was used to normalize numerical variables. This method scales the data to a range between 0 and 1, ensuring that no feature dominates the model due to its scale.</p><p>3-3- Splitting data.</p><p>Train_test_split function in the Sklearn model selection was used to devise database randomly into two subsets, training data (67%) and testing data (33%).</p></sec><sec><title>4) Algorithms</title><p>In this study, three supervised machine learning models were employed:</p></sec><sec><title>5) Hyperparameters tuning (HT) : “GridSearchCV”</title><p>Grid search is an approach to parameter tuning that methodically builds and evaluates a model for each combination of algorithm parameters specified in a grid [<xref ref-type="bibr" rid="cit20">20</xref>].</p></sec><sec><title>6) Cross-validation</title><p>A 5-fold cross-validation approach was employed. The dataset was divided into 5 subsets, with each subset serving as the validation set once while the remaining subsets form the training set. This process ensures that the model is evaluated comprehensively [<xref ref-type="bibr" rid="cit21">21</xref>].</p></sec><sec><title>7) Model measurments</title><p>In order to evaluate the predictive model, various measurements can be calculated such as accuracy, precision, and sensitivity as the following:</p></sec><sec><title>8) Ethical approval</title><p>This study received ethical approval from the Ethics Committee of the Hassan II University Hospital in Fez. All subjects were informed of the study conditions and provided written informed consent. Anonymity and confidentiality were strictly maintained.</p></sec><sec><title>RESULTS</title><p>Within the dataset under examination, missing values were detected across some features such as Marital Status (5.76%), Social Insurance (3.29%), and HBA1C (2.47%). Importantly, none of the features had more than 50% missing values. Therefore, all features were retained for subsequent analysis, ensuring the integrity of the dataset.</p><p>An evaluation of feature importance association with the target variable was conducted. This analysis is depicted in Figure 2, enumerating attributes from the most significant (Evolution Duration and Gender) to the least (Therapeutic Protocol).</p><fig id="fig-2"><caption><p>Figure 2: Diagram illustrating the presence of missing values in yellow lines for each variable.</p><p>Nb Comorbidities: Number of comorbidities.</p></caption><graphic xlink:href="problendo-72-2-g002.jpeg"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/problendo/2026/2/CYXIkkL4a2CsjYJ269nni9DKGq5efrqZVPQSYOxO.jpeg</uri></graphic></fig><p>The obtained results were encouraging in the classification of potentially anxious patients, with the DT algorithm achieving the highest accuracy of 90%, followed by SVM with 66% accuracy, and LR with 63% accuracy. In clinical terms, this means that the DT algorithm correctly identified 90% of patients with anxiety, while SVM and LR correctly identified 66% and 63%, respectively.</p><p>The evaluation of the results involved utilizing measures such as accuracy, precision, sensitivity, and the ROC curve, to assess and compare the performance of different algorithms. The findings, as depicted in Table II and Figure 3, highlight the DT algorithm’s superior performance in distinguishing between anxious and non-anxious patients, followed by SVM and LR, respectively. This data is clinically relevant for endocrinologists as it suggests that using the DT algorithm can significantly enhance the accurate identification of patients with anxiety, facilitating timely and effective intervention and management.</p><table-wrap id="table-2"><caption><p>Table II. Performance comparison of LR, SVM and DT algorithms</p></caption><table><tbody><tr><td>Algorithm</td><td>Accuracy(Testing)</td><td>Sensitivity</td><td>Precision</td><td>ROC</td></tr><tr><td>LR</td><td>61%</td><td>56%</td><td>41%</td><td>60%</td></tr><tr><td>SVM</td><td>69%</td><td>76%</td><td>50%</td><td>71%</td></tr><tr><td>DT</td><td>96%</td><td>96%</td><td>92%</td><td>96%</td></tr></tbody></table></table-wrap><fig id="fig-3"><caption><p>Figure 3: Comparison of different models ROC curves.</p></caption><graphic xlink:href="problendo-72-2-g003.jpeg"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/problendo/2026/2/6wL7RuCUoyCvZJ2hwmSdxYO4kkjsUHmGZjdlY09e.jpeg</uri></graphic></fig></sec><sec><title>DISCUSSION</title><p>This study marks an important contribution to the field by emphasizing the importance of developing a machine learning model specifically tailored for predicting anxiety in Moroccan individuals with diabetes. Anxiety is a prevalent psychological condition that significantly impacts the well-being and quality of life of individuals with diabetes [1-6]. By accurately predicting anxiety, healthcare professionals can implement timely interventions and personalized management strategies to alleviate its impact and improve overall patient outcomes [7–8].</p><p>The use of LR, SVM, and DT machine learning algorithms in this study yielded promising results in terms of predicting anxiety in diabetics. These algorithms demonstrated optimal performance, suggesting their potential utility in real-world applications for anxiety prediction. However, it is important to acknowledge the limitations of this study, particularly the use of a small database that was not specifically designed for this research. The small dataset may have affected the generalizability and robustness of the model, potentially leading to biased or less accurate predictions. To address these limitations, the use of a larger dataset is recommended.</p><p>Having a large number of variables can increase the risk of overfitting because the model may become too complex, capturing noise and random fluctuations in the training data rather than the underlying patterns [<xref ref-type="bibr" rid="cit22">22</xref>]. This can lead to excellent performance on the training data but poor generalization to new, unseen data [<xref ref-type="bibr" rid="cit22">22</xref>]. To avoid this complexity that can led the model to make overly specific predictions that fail to perform well in practical applications, the selection of clinical and laboratory parameters presented in Table 1 was based on their relevance to both diabetes and anxiety, as supported by existing literature [3–6].</p><p>Although in this study there were some features more correlated to the target variable, age, gender, marital status, social insurance status, diabetes type, duration of diabetes, therapeutic protocol, number of comorbidities, and glycated hemoglobin (HbA1c) levels are all factors that have been shown to influence both diabetes management and psychological well-being [3–6]. These parameters were chosen based on their established relevance to provide a comprehensive understanding of the patient’s health status and its potential impact on anxiety levels [3–6].</p><p>To improve anxiety management in individuals with diabetes, implementing an e-framework based on this predictive model and integrating it into routine clinical practice is highly recommended. Studies have shown that predictive models can be effective tools in improving patient outcomes through early identification of at-risk individuals [<xref ref-type="bibr" rid="cit23">23</xref>] .A mobile framework would provide an easy-to-access tool and user-friendly interface for healthcare professionals to input patient data and receive accurate risk assessments for anxiety. While the HADS scale has been effectively used in Morocco [<xref ref-type="bibr" rid="cit15">15</xref>], it requires repeated administration and reevaluation at each clinical consultation, which may not capture early or subtle signs of anxiety [<xref ref-type="bibr" rid="cit24">24</xref>]. In this study, the machine learning model is not intended only for the early diagnosis of anxiety, rather, it is designed to predict the risk of developing anxiety in diabetic patients in the future. Machine learning models have been increasingly recognized for their ability to predict mental health outcomes by analyzing large, complex datasets [<xref ref-type="bibr" rid="cit25">25</xref>]. Unlike traditional methods, which may miss subtle psychological symptoms during routine consultations, machine learning models can continuously analyze a broad range of patient-specific data. This allows for more personalized, dynamic insights that could identify at-risk individuals who may not show obvious signs of anxiety in a standard clinical setting. Although the model may not be more cost-effective, its ability to deliver real-time, tailored predictions can enhance the overall accuracy of risk assessment [<xref ref-type="bibr" rid="cit26">26</xref>] and lead to more personalized treatment strategies for better management of both physical and mental health in diabetic patients.</p><p>The essence of the DT model lies in its simplicity and interpretability. DT models are frequently used in clinical decision-making due to their clarity and ease of use [<xref ref-type="bibr" rid="cit23">23</xref>]. A practitioner can use the DT model by inputting patient data into a software application designed for this purpose. The data entry process is straightforward and typically takes a few minutes, after which the model provides an anxiety prediction. The DT algorithm was the most performant in generating clear and valuable information. Unlike common diagnostic scales for anxiety, the DT model can integrate various clinical parameters and provide a holistic assessment of the patient’s risk [<xref ref-type="bibr" rid="cit27">27</xref>]. This approach not only supports personalized care but also facilitates continuous monitoring and adjustment of treatment plans based on the patient’s evolving health status.</p><p>While the results are promising, it is crucial to consider their implications in a clinical context. The integration of these ML models has the potential to improve the diagnosis and management of anxiety in diabetic patients by enabling early identification and intervention. However, these models have not yet been extensively tested in clinical practice. Future studies should validate their effectiveness and utility in real-world settings, assess their impact on patient outcomes, ease of use for healthcare providers, and overall integration into existing clinical workflows. This validation is essential to ensure the models are both theoretically sound and practically beneficial in improving the quality of care for individuals with diabetes.</p></sec><sec><title>CONCLUSION</title><p>In summary, this study introduces a valuable machine learning model for anxiety prediction in Moroccan diabetics, demonstrating the superiority of the decision tree (DT) algorithm over logistic regression (LR) and support vector machine (SVM) algorithms. The development of a mobile framework application based on the DT model is recommended to facilitate its use in daily clinical practice. By integrating this advanced predictive tool into endocrinological practice, healthcare providers can address both physical and mental health aspects, thereby enhancing patient outcomes and overall quality of life.</p></sec><sec><title>ADDITIONAL INFORMATION</title><p>Funding. No funding. Conflicts of Interest. The author declares no obvious and potential conflicts of interest related to the content of this article Acknowledgments. The author thanks Fatima Sergeevna Datieva for helpful suggestions and critical reading of the manuscript.</p></sec></body><back><ref-list><ref id="cit1"><mixed-citation publication-type="commun" publication-format="web"><name><surname>Saeedi</surname> <given-names>P</given-names></name>, <name><surname>Petersohn</surname> <given-names>I</given-names></name>, <name><surname>Salpea</surname> <given-names>P</given-names></name>, <name><surname>Malanda</surname> <given-names>B</given-names></name>, <name><surname>Karuranga</surname> <given-names>S</given-names></name>, <name><surname>Unwin</surname> <given-names>N</given-names></name>, <name><surname>Colagiuri</surname> <given-names>S</given-names></name>, <name><surname>Guariguata</surname> <given-names>L</given-names></name>, <name><surname>Motala</surname> <given-names>AA</given-names></name>, <name><surname>Ogurtsova</surname> <given-names>K</given-names></name>, <name><surname>Shaw</surname> <given-names>JE</given-names></name>, <name><surname>Bright</surname> <given-names>D</given-names></name>, <name><surname>Williams</surname> <given-names>R</given-names></name>, <article-title>IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition</article-title>. <source>Diabetes Res Clin Pract</source>. nov <year>2019</year>;157:107843.</mixed-citation></ref><ref id="cit2"><mixed-citation publication-type="commun" publication-format="web"><source>Ministère de la santé du Royaume du Maroc.</source> <article-title>Rapport de l’enquête nationale sur les facteurs de risque communs des maladies non transmissibles,</article-title> Steps, 2017-2018 [Internet]. [cité 29 juill 2022]. Disponible sur: https://www.sante.gov.ma/Documents/2019/05/Rapport%20de%20l%20enqu%C3%AAte%20Stepwise.pdf</mixed-citation></ref><ref id="cit3"><mixed-citation publication-type="commun" publication-format="web"><name><surname>Benmaamar</surname> <given-names>S</given-names></name>, <name><surname>Lazar</surname> <given-names>N</given-names></name>, <name><surname>El Harch</surname> <given-names>I</given-names></name>, <name><surname>Maiouak</surname> <given-names>M</given-names></name>, <name><surname>Qarmiche</surname> <given-names>N</given-names></name>, <name><surname>Otmani</surname> <given-names>N</given-names></name>, <name><surname>Salhi</surname> <given-names>H</given-names></name>, <name><surname>Tachfouti</surname> <given-names>N</given-names></name>, <name><surname>El Ouahabi</surname> <given-names>H</given-names></name>, <name><surname>El Fakir</surname> <given-names>S.</given-names></name> <article-title>Depression and anxiety in patients with diabetes in a Moroccan region</article-title>. <source>Encephale</source>. 12 oct <year>2021</year>;S0013-7006(21)00186-X.</mixed-citation></ref><ref id="cit4"><mixed-citation publication-type="commun" publication-format="web"><name><surname>Smith</surname> <given-names>KJ</given-names></name>, <name><surname>Schmitz</surname> <given-names>N.</given-names></name> <article-title>Association of Depression and Anxiety Symptoms With Functional Disability and Disability Days in a Community Sample With Type 2 Diabetes.</article-title> <source>Psychosomatics</source>. 1 <month>nov</month> <year>2014</year>;<issue>55(6)</issue>:<fpage>659</fpage>-<lpage>67</lpage></mixed-citation></ref><ref id="cit5"><mixed-citation publication-type="commun" publication-format="web"><name><surname>Huang</surname> <given-names>CJ</given-names></name>, <name><surname>Hsieh</surname> <given-names>HM</given-names></name>, <name><surname>Tu</surname> <given-names>HP</given-names></name>, <name><surname>Jiang</surname> <given-names>HJ</given-names></name>, <name><surname>Wang</surname> <given-names>PW</given-names></name>, <name><surname>Lin</surname> <given-names>CH.</given-names></name> <article-title>Generalized anxiety disorder in type 2 diabetes mellitus: prevalence and clinical characteristics.</article-title> <source>Braz J Psychiatry.</source> 17 avr <year>2020</year>;<issue>42(6)</issue>:<fpage>621</fpage>-<lpage>9</lpage>.</mixed-citation></ref><ref id="cit6"><mixed-citation publication-type="commun" publication-format="web"><name><surname>Park</surname> <given-names>HS</given-names></name>, <name><surname>Cho</surname> <given-names>Y</given-names></name>, <name><surname>Seo</surname> <given-names>DH</given-names></name>, <name><surname>Ahn</surname> <given-names>SH</given-names></name>, <name><surname>Hong</surname> <given-names>S</given-names></name>, <name><surname>Suh</surname> <given-names>YJ</given-names></name>, <name><surname>Chon</surname> <given-names>S</given-names></name>, <name><surname>Woo</surname> <given-names>JT</given-names></name>, <name><surname>Baik</surname> <given-names>SH</given-names></name>, <name><surname>Lee</surname> <given-names>KW</given-names></name>, <name><surname>Kim</surname> <given-names>SH.</given-names></name> <article-title>Impact of diabetes distress on glycemic control and diabetic complications in type 2 diabetes mellitus</article-title>. Sci Rep. 6 mars <year>2024</year>;<issue>14</issue>:5568.</mixed-citation></ref><ref id="cit7"><mixed-citation publication-type="commun" publication-format="web"><name><surname>Gomathy</surname> <given-names>CK.</given-names></name> <article-title>The prediction of disease using machine learning</article-title>. <source>International Journal of Scientific Research in Engineering and Management (IJSREM)</source>. 31 déc <year>2021</year>.</mixed-citation></ref><ref id="cit8"><mixed-citation publication-type="commun" publication-format="web"><name><surname>Topol</surname> <given-names>EJ.</given-names></name> <article-title>High-performance medicine: the convergence of human and artificial intelligence</article-title>. <source>Nat Med</source>. janv <year>2019</year>;<issue>25(1)</issue>:<fpage>44</fpage>-<lpage>56</lpage>.</mixed-citation></ref><ref id="cit9"><element-citation><name><surname>Pintelas</surname> <given-names>Emmanuel G.</given-names> </name> <name><surname>Kotsilieris</surname> <given-names>Theodore</given-names> </name> <name><surname>Livieris</surname> <given-names>Ioannis E.</given-names> </name> <name><surname>Pintelas</surname> <given-names>Panagiotis</given-names> </name> <article-title>A review of machine learning prediction methods for anxiety disorders</article-title> <source>Proceedings of the 8th International Conference on Software Development and Technologies for Enhancing Accessibility and Fighting Info-exclusion</source> <year>2019</year> <month>01</month> <fpage>8</fpage> <lpage>15</lpage> <object-id pub-id-type="doi" specific-use="metadata">10.1145/3218585.3218587</object-id></element-citation></ref><ref id="cit10"><mixed-citation publication-type="commun" publication-format="web"><name><surname>Kumar</surname> <given-names>P.</given-names></name> <article-title>Assessment of Anxiety, Depression and Stress using Machine Learning Models</article-title>. <source>Procedia Computer Science</source>. 1 janv <year>2020</year>;<issue>171</issue>:<fpage>1989</fpage>-<lpage>98</lpage>.</mixed-citation></ref><ref id="cit11"><mixed-citation publication-type="commun" publication-format="web"><name><surname>Nemesure</surname> <given-names>MD</given-names></name>, <name><surname>Heinz</surname> <given-names>MV</given-names></name>, <name><surname>Huang</surname> <given-names>R</given-names></name>, <name><surname>Jacobson</surname> <given-names>NC.</given-names></name> <article-title>Predictive modeling of depression and anxiety using electronic health records and a novel machine learning approach with artificial intelligence</article-title>. <source>Sci Rep</source>. 21 janv <year>2021</year>;<issue>11(1)</issue>:<lpage>1980</lpage>.</mixed-citation></ref><ref id="cit12"><mixed-citation publication-type="commun" publication-format="web"><name><surname>Bourkhime</surname> <given-names>H</given-names></name>, <name><surname>Qarmiche</surname> <given-names>N</given-names></name>, <name><surname>Bahra</surname> <given-names>N</given-names></name>, <name><surname>Omari</surname> <given-names>M</given-names></name>, <name><surname>Chakri</surname> <given-names>I</given-names></name>, <name><surname>Berraho</surname> <given-names>M</given-names></name>, <name><surname>Tachfouti</surname> <given-names>N</given-names></name>, <name><surname>Fakir</surname> <given-names>SEL</given-names></name>, <name><surname>Otmani</surname> <given-names>N.</given-names></name> <article-title>Classification of Depression, Anxiety, and Quality of Life in Diabetic Patients with Machine Learning: Systematic Review</article-title>. In: Farhaoui Y, Hussain A, Saba T, Taherdoost H, Verma A, éditeurs. <source>Artificial Intelligence, Data Science and Applications</source>. Cham: Springer Nature Switzerland; <year>2024</year>. p. <fpage>263</fpage>-<lpage>70</lpage>. (Lecture Notes in Networks and Systems).</mixed-citation></ref><ref id="cit13"><mixed-citation publication-type="commun" publication-format="web"><name><surname>Yu</surname> <given-names>J</given-names></name>, <name><surname>Chiu</surname> <given-names>C</given-names></name>, <name><surname>Wang</surname> <given-names>Y</given-names></name>, <name><surname>Dzubur</surname> <given-names>E</given-names></name>, <name><surname>Lu</surname> <given-names>W</given-names></name>, <name><surname>Hoffman</surname> <given-names>J.</given-names></name> <article-title>A Machine Learning Approach to Passively Informed Prediction of Mental Health Risk in People with Diabetes: Retrospective Case-Control Analysis</article-title>. <source>Journal of Medical Internet Research</source>. 27 août <year>2021</year>;<issue>23(8)</issue>:e27709.</mixed-citation></ref><ref id="cit14"><mixed-citation publication-type="commun" publication-format="web"><name><surname>Zigmond</surname> <given-names>AS</given-names></name>, <name><surname>Snaith</surname> <given-names>RP.</given-names></name> <article-title>The hospital anxiety and depression scale.</article-title> <source>Acta Psychiatr Scand.</source> juin <year>1983</year>;<issue>67(6)</issue>:<fpage>361</fpage>-<lpage>70</lpage>.</mixed-citation></ref><ref id="cit15"><mixed-citation publication-type="commun" publication-format="web"><name><surname>Bendahhou</surname> <given-names>K</given-names></name>, <name><surname>Serhir</surname> <given-names>Z</given-names></name>, <name><surname>Ibrahim Khalil</surname> <given-names>A</given-names></name>, <name><surname>Radallah</surname> <given-names>D</given-names></name>, <name><surname>Amegrissi</surname> <given-names>S</given-names></name>, <name><surname>Battas</surname> <given-names>O</given-names></name>, <name><surname>Benider</surname> <given-names>A.</given-names></name> <article-title>Validation de la version dialectale Marocaine de l’échelle « HADS »</article-title>. <source>Revue d’Épidémiologie et de Santé Publique</source>. 1 mai <year>2017</year>;<issue>65</issue>:S53.</mixed-citation></ref><ref id="cit16"><mixed-citation publication-type="commun" publication-format="web">https://cran.r-project.org/web/packages/missCompare/vignettes/misscompare.html</mixed-citation></ref><ref id="cit17"><mixed-citation publication-type="commun" publication-format="web"><name><surname>Subasi</surname> <given-names>A.</given-names></name> <article-title>Machine learning techniques</article-title>. In: <source>Practical Machine Learning for Data Analysis Using Python</source> [Internet]. Elsevier; <year>2020</year> [cité 28 juill 2022]. p. 91 202. Disponible sur: https://linkinghub.elsevier.com/retrieve/pii/B9780128213797000035</mixed-citation></ref><ref id="cit18"><mixed-citation publication-type="commun" publication-format="web"><name><surname>Thorsten</surname> <given-names>J.</given-names></name> <source>Making Large-Scale SVM Learning Practical. Advances in Kernel Methods - Support Vector Learning</source>, Bernhard Scholkopf, Christopher J. C. Burges, and Alexander J. Smola (eds.), MIT Press, Cambridge, USA, 1998. Disponible sur: https://www.cs.cornell.edu/people/tj/publications/joachims_99a.pdf</mixed-citation></ref><ref id="cit19"><mixed-citation publication-type="commun" publication-format="web"><name><surname>Navada</surname> <given-names>A</given-names></name>, <name><surname>Ansari</surname> <given-names>A</given-names></name>, <name><surname>Patil</surname> <given-names>S</given-names></name>, <name><surname>Sonkamble</surname> <given-names>B.</given-names></name> <article-title>Overview of use of decision tree algorithms in machine learning</article-title>. <source>Proceedings - 2011 IEEE Control and System Graduate Research Colloquium</source>, ICSGRC 2011. <year>2011</year>. <lpage>37</lpage> p.</mixed-citation></ref><ref id="cit20"><mixed-citation publication-type="commun" publication-format="web"><name><surname>Padierna</surname> <given-names>L</given-names></name>, <name><surname>Carpio</surname> <given-names>M</given-names></name>, <name><surname>Rojas-Dominguez</surname> <given-names>A</given-names></name>, <name><surname>Soberanes</surname> <given-names>H</given-names></name>, <name><surname>Baltazar</surname> <given-names>R</given-names></name>, <name><surname>Fraire-Huacuja</surname> <given-names>H.</given-names></name> <article-title>Hyper-Parameter Tuning for Support Vector Machines by Estimation of Distribution Algorithms</article-title>. In <year>2017</year>. p. <fpage>787</fpage>-<lpage>800</lpage>.</mixed-citation></ref><ref id="cit21"><mixed-citation publication-type="commun" publication-format="web"><name><surname>Berrar</surname> <given-names>D.</given-names></name> <article-title>Cross-Validation</article-title>. <source>Encyclopedia of Bioinformatics and Computational Biology, Volume 1</source>, Elsevier, pp. <fpage>542</fpage>–<lpage>545</lpage>. In 2018. https://doi.org/<object-id pub-id-type="doi" specific-use="metadata">10.1016/B978-0-12-809633-8.20349-X1</object-id></mixed-citation></ref><ref id="cit22"><mixed-citation publication-type="commun" publication-format="web"><name><surname>Van der Schaaf</surname> <given-names>A</given-names></name>, <name><surname>Xu</surname> <given-names>CJ</given-names></name>, <name><surname>van Luijk</surname> <given-names>P</given-names></name>, <name><surname>van’t Veld</surname> <given-names>AA</given-names></name>, <name><surname>Langendijk</surname> <given-names>JA</given-names></name>, <name><surname>Schilstra</surname> <given-names>C.</given-names></name> <article-title>Multivariate modeling of complications with data driven variable selection: Guarding against overfitting and effects of data set size</article-title>. <source>Radiotherapy and Oncology</source>. 1 <month>oct</month> <year>2012</year>;<issue>105(1)</issue>:<fpage>115</fpage>-<lpage>21</lpage>.</mixed-citation></ref><ref id="cit23"><mixed-citation publication-type="commun" publication-format="web"><name><surname>Toma</surname> <given-names>M</given-names></name>, <name><surname>Wei</surname> <given-names>OC.</given-names></name> <article-title>Predictive Modeling in Medicine</article-title>. <source>Encyclopedia</source>. juin <year>2023</year>;<issue>3(2)</issue>:<fpage>590</fpage>-<lpage>601</lpage>.</mixed-citation></ref><ref id="cit24"><mixed-citation publication-type="commun" publication-format="web"><name><surname>Bjelland</surname> <given-names>I</given-names></name>, <name><surname>Dahl</surname> <given-names>AA</given-names></name>, <name><surname>Haug</surname> <given-names>TT</given-names></name>, <name><surname>Neckelmann</surname> <given-names>D.</given-names></name> <article-title>The validity of the Hospital Anxiety and Depression Scale: An updated literature review</article-title>. <source>Journal of Psychosomatic Research</source>. 1 févr <year>2002</year>;<issue>52(2)</issue>:<fpage>69</fpage>-<lpage>77</lpage>.</mixed-citation></ref><ref id="cit25"><mixed-citation publication-type="commun" publication-format="web"><name><surname>Shatte</surname> <given-names>ABR</given-names></name>, <name><surname>Hutchinson</surname> <given-names>DM</given-names></name>, <name><surname>Teague</surname> <given-names>SJ.</given-names></name> <article-title>Machine learning in mental health: a scoping review of methods and applications</article-title>. <source>Psychol Med</source>. juill <year>2019</year>;<issue>49(9)</issue>:<fpage>1426</fpage>-<lpage>48</lpage>.</mixed-citation></ref><ref id="cit26"><mixed-citation publication-type="commun" publication-format="web"><name><surname>Topol</surname> <given-names>EJ.</given-names></name> <article-title>High-performance medicine: the convergence of human and artificial intelligence</article-title>. <source>Nat Med</source>. janv <year>2019</year>;<issue>25(1)</issue>:<fpage>44</fpage>-<lpage>56</lpage>.</mixed-citation></ref><ref id="cit27"><mixed-citation publication-type="commun" publication-format="web"><name><surname>Breiman</surname> <given-names>L</given-names></name>, <name><surname>Friedman</surname> <given-names>J</given-names></name>, <name><surname>Olshen</surname> <given-names>RA</given-names></name>, <name><surname>Stone</surname> <given-names>CJ.</given-names></name> <article-title>Classification and Regression Trees</article-title>. New York: Chapman and Hall/CRC; <year>2017</year>. <lpage>368</lpage> p.</mixed-citation></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
